Hematologic Malignancy
Transformed Small Lymphocytic Lymphoma to Diffuse Large B-Cell Lymphoma
CI-CAN-00008565Explore in graph →
Hematologic1 active trials
- NCIt
- C157625
Loading cancer entity…
Hematologic Malignancy
CI-CAN-00008565Explore in graph →
Clinical trials
3 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (1)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT07220187 | Adding Pirtobrutinib to the Usual Treatment for People With Newly Diagnosed Richter Transformation, The PIRAMID Trial | not yet recruiting | Phase 3 | 102 | SWOG Cancer Research NetworkNETWORK | 0 | Jun 11, 2026 | clinicaltrials |
| NCT03892044 | Duvelisib and Nivolumab in Treating Patients With Richter Syndrome or Transformed Follicular Lymphoma | completed | Phase 1 | 7 | David Bond, MDOTHER | 1 | May 2, 2024 | clinicaltrials |
| NCT06247540 |
| Venetoclax, Rituximab and Nivolumab in Combination for the Treatment of Richter's Transformation Arising From Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma |
| withdrawn |
| Phase 2 |
| 0 |
| Northwestern UniversityOTHER |
| 1 |
| Feb 29, 2024 |
| clinicaltrials |
Data updated 22 days agoSource updated Jun 11, 2026source: clinicaltrials